{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"valinemia","columns":[{"gene":"","key":"population-34f29cbd7de1ef4e9782","label":"VALINEMIA","mondoId":"MONDO:0010174","onsetQualifier":null,"originColumnKey":"MONDO:0010174/OMIM:277100","originalViews":[{"key":"MONDO:0010174/OMIM:277100","label":"VALINEMIA","scopeLabel":"OMIM:277100","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["030d36f1544059a39ee5e97f7ecc3a2bb624f51ee571bd8e9c2d33423a4b2332","117e8c7d5bf549f491631c7c033a399f7840cc3ff8cf962e69ac2c19f8e1c0d4","66791f94f7b2da6e488a30c16f87bcc690c5aea20cb67aab90c6f326e3b48009","929d1f0d07ca43aca48d1e4534d1cdfdb82855344e6bd3c3181226a2a2220f59","95b9df0183af01e6a4be978308a2cc603eae78ddd740487927fea1930dce5054","9930971d85dde100fc193d1bc1f2095acf801cab56e683de485f46cc808e7162","bb497c786da9eda64c126a1811b4a3e8e0def9d2669a23efb93e37f6ce5db9d8"],"recordQualifiers":{},"scopeLabel":"OMIM:277100","sourceIds":["OMIM:277100"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-34f29cbd7de1ef4e9782"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002329","HP:0001508","HP:0002487","HP:0010910","HP:0001324","HP:0033088","HP:0002013"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"omim":7}},"features":[{"hpoId":"HP:0002329","label":"Drowsiness","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0002487","label":"Hyperkinetic movements","primary":true},{"hpoId":"HP:0010910","label":"Hypervalinemia","primary":true},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":true},{"hpoId":"HP:0033088","label":"Valinuria","primary":true},{"hpoId":"HP:0002013","label":"Vomiting","primary":true}],"ledeHtml":"Valinemia is a very rare metabolic disorder characterized by abnormally high levels of the amino acid valine in the blood and urine.Infants with valinemia reportedly experience lack of appetite, vomiting, and failure to thrive. In some cases, the condition may be life-threatening. Low muscle tone (hypotonia), excessive drowsiness, hyperactivity, and developmental delay have also been reported. Valinemia is caused by a deficiency of the enzymevaline transaminase, which is needed for the breakdown (metabolism) of valine in the body. It is inherited in an autosomal recessive manner, although the gene responsible for the condition is not yet known. Treatment includes adiet low in valine (introduced during early infancy) which usually improves symptoms and brings valine levels to normal.","mondoId":"MONDO:0010174","node":{"canonicalSlug":"valinemia","comparisons":[{"documentSha256":"2ebc64d18281a8b3f7b0c034513aa731c4f6d9efa3b06d0da44b43fc1f26281c","key":"legacy-valinemia","kind":"legacy","label":"Valinemia","memberIds":["MONDO:0010174"],"mondoId":"MONDO:0010174","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/valinemia.2ebc64d18281a8b3f7b0c034513aa731c4f6d9efa3b06d0da44b43fc1f26281c.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Valinemia","paragraphs":["Valinemia is a very rare metabolic disorder characterized by abnormally high levels of the amino acid valine in the blood and urine.Infants with valinemia reportedly experience lack of appetite, vomiting, and failure to thrive. In some cases, the condition may be life-threatening. Low muscle tone (hypotonia), excessive drowsiness, hyperactivity, and developmental delay have also been reported. Valinemia is caused by a deficiency of the enzymevaline transaminase, which is needed for the breakdown (metabolism) of valine in the body. It is inherited in an autosomal recessive manner, although the gene responsible for the condition is not yet known. Treatment includes adiet low in valine (introduced during early infancy) which usually improves symptoms and brings valine levels to normal."],"scope":"exact","source":"MONDO","upstream":"https://rarediseases.info.nih.gov/diseases/7845/valinemia","url":"https://monarchinitiative.org/MONDO:0010174"},"ownColumnKeys":["population-34f29cbd7de1ef4e9782"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"030d36f1544059a39ee5e97f7ecc3a2bb624f51ee571bd8e9c2d33423a4b2332","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"117e8c7d5bf549f491631c7c033a399f7840cc3ff8cf962e69ac2c19f8e1c0d4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0033088","is_excluded":false,"label":"Valinuria","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"66791f94f7b2da6e488a30c16f87bcc690c5aea20cb67aab90c6f326e3b48009","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002487","is_excluded":false,"label":"Hyperkinetic movements","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"929d1f0d07ca43aca48d1e4534d1cdfdb82855344e6bd3c3181226a2a2220f59","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"95b9df0183af01e6a4be978308a2cc603eae78ddd740487927fea1930dce5054","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010910","is_excluded":false,"label":"Hypervalinemia","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9930971d85dde100fc193d1bc1f2095acf801cab56e683de485f46cc808e7162","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bb497c786da9eda64c126a1811b4a3e8e0def9d2669a23efb93e37f6ce5db9d8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:277100","disease_name":"VALINEMIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"OMIM:277100","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0010174\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://rarediseases.info.nih.gov/diseases/7845/valinemia</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Valinemia is a very rare metabolic disorder characterized by abnormally high levels of the amino acid valine in the blood and urine.Infants with valinemia reportedly experience lack of appetite, vomiting, and failure to thrive. In some cases, the condition may be life-threatening. Low muscle tone (hypotonia), excessive drowsiness, hyperactivity, and developmental delay have also been reported. Valinemia is caused by a deficiency of the enzymevaline transaminase, which is needed for the breakdown (metabolism) of valine in the body. It is inherited in an autosomal recessive manner, although the gene responsible for the condition is not yet known. Treatment includes adiet low in valine (introduced during early infancy) which usually improves symptoms and brings valine levels to normal.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0010174\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"valinemia","sourceDocuments":[{"name":"MONDO: Valinemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0010174"}],"sourceNote":"","synonyms":["Valinemia"],"takeawayHtml":"","title":"Valinemia"},"schemaVersion":1}
